Method and device for detecting feline immunodeficiency virus

Details Method and device for detecting feline immunodeficiency virus Method and device for detecting feline immunodeficiency virus

2007-10-23

2007-10-23

Parkin, Jeffrey S. (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C424S185100, C424S186100, C424S187100, C424S188100

Reexamination Certificate

active

11015675

ABSTRACT:
A method and device for determining a feline immunodeficiency virus infection or vaccination in an animal. The method includes contacting a biological sample from a felid with various FIV polypeptides and determining the binding of antibodies in the sample to the polypeptides. The determination of whether an animal is infected with FIV or has been vaccinated against FIV can be determined by measuring the animal's immune response to an FIV env polypeptide. A device for detecting FIV antibodies is provided.

REFERENCES:
patent: 4629783 (1986-12-01), Cosand
patent: 4879212 (1989-11-01), Wang et al.
patent: 4900548 (1990-02-01), Kitchen
patent: 5037753 (1991-08-01), Pedersen et al.
patent: 5118602 (1992-06-01), Pedersen et al.
patent: 5177014 (1993-01-01), O'Connor et al.
patent: 5219725 (1993-06-01), O'Connor et al.
patent: 5565319 (1996-10-01), Pedersen et al.
patent: 5576177 (1996-11-01), Fridland et al.
patent: 5591572 (1997-01-01), Kemp et al.
patent: 5627026 (1997-05-01), O'Connor et al.
patent: 5648209 (1997-07-01), Avrameas et al.
patent: 5656732 (1997-08-01), Andersen et al.
patent: 5705331 (1998-01-01), Arthur et al.
patent: 5726013 (1998-03-01), Clark
patent: 5736378 (1998-04-01), Elder et al.
patent: 5750333 (1998-05-01), Clark
patent: 5820869 (1998-10-01), Wasmoen et al.
patent: 5833993 (1998-11-01), Wardley
patent: 5846825 (1998-12-01), Yamamoto
patent: 5849303 (1998-12-01), Wasmoen et al.
patent: 5994516 (1999-11-01), Pancino et al.
patent: 6077662 (2000-06-01), Compans et al.
patent: 6228608 (2001-05-01), Young et al.
patent: 6254872 (2001-07-01), Yamamoto
patent: 6284253 (2001-09-01), Barr et al.
patent: 6300118 (2001-10-01), Chavez et al.
patent: 6331616 (2001-12-01), Tompkins et al.
patent: 6383765 (2002-05-01), Andersen et al.
patent: 6391304 (2002-05-01), Richardson et al.
patent: 6447993 (2002-09-01), Yamamoto
patent: 6455265 (2002-09-01), Serres
patent: 6458528 (2002-10-01), Groat et al.
patent: 6503713 (2003-01-01), Rana
patent: 6613530 (2003-09-01), Wienhues et al.
patent: 0 602 406 (1997-11-01), None
patent: 0 962 774 (1999-12-01), None
patent: WO 90/06510 (1990-06-01), None
patent: WO/90/13573 (1990-11-01), None
patent: WO 92/09632 (1992-06-01), None
patent: WO 9209632 (1992-06-01), None
patent: WO 92/22573 (1992-12-01), None
patent: WO 93/01304 (1993-01-01), None
patent: WO 94/02612 (1994-02-01), None
patent: WO 94/06471 (1994-03-01), None
patent: WO 96/40268 (1996-12-01), None
patent: WO 96/40953 (1996-12-01), None
patent: WO 96/40956 (1996-12-01), None
patent: WO 96/40957 (1996-12-01), None
patent: WO 97/07817 (1997-03-01), None
patent: WO 99/29182 (1999-06-01), None
patent: WO 01/04280 (2001-01-01), None
patent: WO 03/015814 (2003-02-01), None
patent: WO 2004/100985 (2004-11-01), None
Ponsati et al. A synthetic strategy for simultaneous purification-conjugation of antigenic peptides. Analytical Biochemistry Sep. 1989 , vol. 181, No. 2, p. 389-395.
U.S. Appl. No. 10/938,097, filed Sep. 10, 2004, Groat et al.
U.S. Appl. No. 10/938,056, filed Sep. 10, 2004, Groat et al.
U.S. Appl. No. 11/059,285, filed Feb. 16, 2005, Groat et al.
U.S. Appl. No. 11/076,820, filed Mar. 10, 2005, Groat et al.
U.S. Appl. No. 11/077,321, filed Mar. 10, 2005, Groat et al.
U.S. Appl. No. 11/075,480, filed Mar. 9, 2005, Groat et al.
U.S. Appl. No. 11/075,958, filed Mar. 9, 2005, Groat et al.
Olmsted, R.A. et al, “Molecular cloning of the feline immunodeficiency virus”,Proc. Nat. Acad. Sci. USA, 1989, vol. 86, pp. 2448-2452.
Maki, N. et al., “Molecular Characterization and Heterogeneity of Feline Immunodeficiency Virus Isolates”,Archives of Virolology, 1992, vol. 123, pp. 29-45.
Yamamoto, J.K. et al., “Experimental Vaccine Protection against Homologous and Heterologous Strains of Feline Immunodeficiency Virus”,Journal of Virology, 1993, vol. 67, No. 1, pp. 601-605.
Hohdatsu, T. et al., “Effect of Dual-subtype Vaccine Against Feline Immunodeficiency Virus Infection”,Veterinary Microbiology, 1997, vol. 58, pp. 155-165.
Uhl, E.W. et al., “FIV Vaccine Development and its Importance to Veterinary and Human Medicine: A Review FIV Vaccine 2002 Update and Review”,Veterinary Immunology and Immunopathology, 2002, vol. 90, pp. 133-132.
Murray, D.M., “Identifying FIV Vaccinates”,Journal of the American Veterinary Medical Association, 2003, vol. 222, p. 710.
Moon, D., “Another Solution to Identify FIV-Vaccinated Cats”,Journal of the American Veterinary Medical Association, 2003, vol. 22, No. 9, p. 1207.
Calandrella, M., “Desitometric Analysis of Western Blot Assays for Feline Immunodeficiency Virus Antibodies”,Veterinary Immunology and Immunopathology, 2001, vol. 79, pp. 261-271.
Hartmann, K. et al., “Comparison of Six In-House Tests for the Rapid Diagnosis of Feline Immunodeficiency and Feline Leukemia Virus Infections”,The Veterinary Record, 2001, vol. 149, pp. 317-320.
Richardson, J., et al., “Delayed Infection after Immunization with a peptide from the Transmembrane Glycoprotein of the Feline Immunodeficiency Virus”,Journal of Virology, 1998, vol. 72, pp. 2406-2415.
Finerty, Susan, et al., “Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge”,Vaccine, 2000, vol. 18, pp. 3254-3265.
DeRonde, Anthony, et al., “Antibody Response in Cats to the Envelope Proteins of Feline Immunodeficincy Virus: identification of an Immunodominant Neutralization Domain”,Virology, 1994, vol. 198, pp. 257-264.
Lombardi, Stefania, et al., “Identification of a Linear Neutralization Site within the Third Variable region of Feline Immunodeficiency Virus Envelope”,Journal of Virology, 1993, vol. 67, pp. 4742-4749.
Avrameas, A., et al., “Localisation of Three Epitopes of the ENV Protein of Feline Immunodeficiency Virus”,Molecular Immunology, 1992, vol. 29, pp. 565-572.
Avrameas, A., et al., “Serological Diagnosis of Feline Immunodeficiency Virus Infection Based on Synthetic Peptides from Env Glycoproteins”,Res. Virol, 1993, vol. 144, pp. 209-218.
Olmsted, Robert , “Nucleotide Sequence Analysis of Feline Immunodeficiency Virus: Genome Organization and Relationship to Other Lentiviruses”,Proc. Natl. Acad. Sci. USA, 1989, vol. 86, pp. 8088-8092.
Gallaher, William, et et al., “A General Model for the Transmembrane Proteins of HIV and Other Retroviruses”,AIDS Research and Human Retroviruses, 1989, vol. 5, pp. 431-440.
Mermer, B., et al., “Similarities Between the Transmembrane Proteins of FIV and HIV”,Abstract distributed on and Poster Presentation during the Cold Spring Harbor Conference, 1991.
Javaherian, et al., “Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein”,Proc. Natl. Acad. Sci. USA, 1989, vol. 86, pp. 6768-6772.
Steinman, et al., “Biochemical and Immunological Characterization of the Major Structural Proteins of Feline Immunodeficiency Virus”,Journal of General Virology, 1990, vol. 71, pp. 701-706.
Gnann, et al, “Fine Mapping of an Immunodominant Domain in the Transmembrane Glycoprotein of Human Immunodeficiency Virus”,Journal of Virology, 1987, vol. 61, pp. 2639-2641.
Chong, et al., “Analysis of Equine Humoral Immune Responses to the Transmembrane Envelope Glycoprotein (gp45) of Equine Infectious Anemia Virus”,Journal of Virology, 1991, pp. 1013-1018.
Berton, et al., “The Antigenic Structure of the Influenza B Virus Hemagglutinin: Operational and Topological Mapping with Monoclonal Antibodies”, Virology, 1985, vol. 143, pp. 583-594.
Mermer, et al., “A Recombinant-based Feline Immunodeficiency Virus Antibody Enzyme-Linked Immunosorbent Assay”,Veterinary Immunology and Immunopathology, 1992, vol. 35, pp. 133-141.
Massi, et al., “Most Potential Linear B Cell Epitopes of Env Glycoproteins of Feline Immunodeficiency V

Affiliated with

Also associated with

Rating

Method and device for detecting feline immunodeficiency virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and device for detecting feline immunodeficiency virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and device for detecting feline immunodeficiency virus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3829724